LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: Targeting the Oncogenic Long Non-coding RNA SLNCR1 by Blocking Its Sequence-Specific Binding to the Androgen Receptor.

    Schmidt, Karyn / Weidmann, Chase A / Hilimire, Thomas A / Yee, Elaine / Hatfield, Breanne M / Schneekloth, John S / Weeks, Kevin M / Novina, Carl D

    Cell reports

    2020  Volume 30, Issue 2, Page(s) 541–554.e5

    Abstract: Long non-coding RNAs (lncRNAs) are critical regulators of numerous physiological processes and diseases, especially cancers. However, development of lncRNA-based therapies is limited because the mechanisms of many lncRNAs are obscure, and interactions ... ...

    Abstract Long non-coding RNAs (lncRNAs) are critical regulators of numerous physiological processes and diseases, especially cancers. However, development of lncRNA-based therapies is limited because the mechanisms of many lncRNAs are obscure, and interactions with functional partners, including proteins, remain uncharacterized. The lncRNA SLNCR1 binds to and regulates the androgen receptor (AR) to mediate melanoma invasion and proliferation in an androgen-independent manner. Here, we use biochemical analyses coupled with selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE) RNA structure probing to show that the N-terminal domain of AR binds a pyrimidine-rich motif in an unstructured region of SLNCR1. This motif is predictive of AR binding, as we identify an AR-binding motif in lncRNA HOXA11-AS-203. Oligonucleotides that bind either the AR N-terminal domain or the AR RNA motif block the SLNCR1-AR interaction and reduce SLNCR1-mediated melanoma invasion. Delivery of oligos that block SLNCR1-AR interaction thus represent a plausible therapeutic strategy.
    MeSH term(s) Base Sequence ; Cell Line, Tumor ; Cell Proliferation/physiology ; Female ; HEK293 Cells ; Humans ; Male ; Melanoma/genetics ; Melanoma/metabolism ; Melanoma/pathology ; Neoplasm Invasiveness ; Protein Domains ; RNA, Long Noncoding/genetics ; RNA, Long Noncoding/metabolism ; RNA, Neoplasm/genetics ; RNA, Neoplasm/metabolism ; Receptors, Androgen/genetics ; Receptors, Androgen/metabolism
    Chemical Substances AR protein, human ; RNA, Long Noncoding ; RNA, Neoplasm ; Receptors, Androgen ; long non-coding RNA SLNCR1, human
    Language English
    Publishing date 2020-01-15
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, N.I.H., Intramural
    ZDB-ID 2649101-1
    ISSN 2211-1247 ; 2211-1247
    ISSN (online) 2211-1247
    ISSN 2211-1247
    DOI 10.1016/j.celrep.2019.12.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Rare loss of function variants in the hepatokine gene INHBE protect from abdominal obesity.

    Deaton, Aimee M / Dubey, Aditi / Ward, Lucas D / Dornbos, Peter / Flannick, Jason / Yee, Elaine / Ticau, Simina / Noetzli, Leila / Parker, Margaret M / Hoffing, Rachel A / Willis, Carissa / Plekan, Mollie E / Holleman, Aaron M / Hinkle, Gregory / Fitzgerald, Kevin / Vaishnaw, Akshay K / Nioi, Paul

    Nature communications

    2022  Volume 13, Issue 1, Page(s) 4319

    Abstract: Identifying genetic variants associated with lower waist-to-hip ratio can reveal new therapeutic targets for abdominal obesity. We use exome sequences from 362,679 individuals to identify genes associated with waist-to-hip ratio adjusted for BMI ( ... ...

    Abstract Identifying genetic variants associated with lower waist-to-hip ratio can reveal new therapeutic targets for abdominal obesity. We use exome sequences from 362,679 individuals to identify genes associated with waist-to-hip ratio adjusted for BMI (WHRadjBMI), a surrogate for abdominal fat that is causally linked to type 2 diabetes and coronary heart disease. Predicted loss of function (pLOF) variants in INHBE associate with lower WHRadjBMI and this association replicates in data from AMP-T2D-GENES. INHBE encodes a secreted protein, the hepatokine activin E. In vitro characterization of the most common INHBE pLOF variant in our study, indicates an in-frame deletion resulting in a 90% reduction in secreted protein levels. We detect associations with lower WHRadjBMI for variants in ACVR1C, encoding an activin receptor, further highlighting the involvement of activins in regulating fat distribution. These findings highlight activin E as a potential therapeutic target for abdominal obesity, a phenotype linked to cardiometabolic disease.
    MeSH term(s) Activin Receptors, Type I/genetics ; Body Mass Index ; Diabetes Mellitus, Type 2/genetics ; Humans ; Inhibin-beta Subunits/genetics ; Obesity/genetics ; Obesity, Abdominal/genetics ; Waist-Hip Ratio
    Chemical Substances INHBE protein, human ; Inhibin-beta Subunits (93443-12-0) ; ACVR1C protein, human (EC 2.7.11.30) ; Activin Receptors, Type I (EC 2.7.11.30)
    Language English
    Publishing date 2022-07-27
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-022-31757-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The lncRNA SLNCR Recruits the Androgen Receptor to EGR1-Bound Genes in Melanoma and Inhibits Expression of Tumor Suppressor p21.

    Schmidt, Karyn / Carroll, Johanna S / Yee, Elaine / Thomas, Dolly D / Wert-Lamas, Leon / Neier, Steven C / Sheynkman, Gloria / Ritz, Justin / Novina, Carl D

    Cell reports

    2019  Volume 27, Issue 8, Page(s) 2493–2507.e4

    Abstract: Melanoma is the deadliest form of skin cancer, affecting men more frequently and severely than women. Although recent studies suggest that differences in activity of the androgen receptor (AR) underlie the observed sex bias, little is known about AR ... ...

    Abstract Melanoma is the deadliest form of skin cancer, affecting men more frequently and severely than women. Although recent studies suggest that differences in activity of the androgen receptor (AR) underlie the observed sex bias, little is known about AR activity in melanoma. Here we show that AR and EGR1 bind to the long non-coding RNA SLNCR and increase melanoma proliferation through coordinated transcriptional regulation of several growth-regulatory genes. ChIP-seq reveals that ligand-free AR is enriched on SLNCR-regulated melanoma genes and that AR genomic occupancy significantly overlaps with EGR1 at consensus EGR1 binding sites. We present a model in which SLNCR recruits AR to EGR1-bound genomic loci and switches EGR1-mediated transcriptional activation to repression of the tumor suppressor p21
    MeSH term(s) Binding Sites ; Cell Line, Tumor ; Cell Proliferation ; Cyclin-Dependent Kinase Inhibitor p21/genetics ; Cyclin-Dependent Kinase Inhibitor p21/metabolism ; Early Growth Response Protein 1/chemistry ; Early Growth Response Protein 1/metabolism ; Female ; G1 Phase Cell Cycle Checkpoints ; Gene Expression Regulation, Neoplastic ; Humans ; Ligands ; Male ; Melanoma/genetics ; Melanoma/metabolism ; Melanoma/pathology ; Protein Binding ; RNA Interference ; RNA, Long Noncoding/antagonists & inhibitors ; RNA, Long Noncoding/genetics ; RNA, Long Noncoding/metabolism ; RNA, Small Interfering/metabolism ; Receptors, Androgen/chemistry ; Receptors, Androgen/genetics ; Receptors, Androgen/metabolism ; Transcriptional Activation ; Tumor Suppressor Protein p53/metabolism
    Chemical Substances Cyclin-Dependent Kinase Inhibitor p21 ; EGR1 protein, human ; Early Growth Response Protein 1 ; Ligands ; RNA, Long Noncoding ; RNA, Small Interfering ; Receptors, Androgen ; TP53 protein, human ; Tumor Suppressor Protein p53 ; long non-coding RNA SLNCR1, human
    Language English
    Publishing date 2019-05-21
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2649101-1
    ISSN 2211-1247 ; 2211-1247
    ISSN (online) 2211-1247
    ISSN 2211-1247
    DOI 10.1016/j.celrep.2019.04.101
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Characterising a healthy adult with a rare HAO1 knockout to support a therapeutic strategy for primary hyperoxaluria.

    McGregor, Tracy L / Hunt, Karen A / Yee, Elaine / Mason, Dan / Nioi, Paul / Ticau, Simina / Pelosi, Marissa / Loken, Perry R / Finer, Sarah / Lawlor, Deborah A / Fauman, Eric B / Huang, Qin Qin / Griffiths, Christopher J / MacArthur, Daniel G / Trembath, Richard C / Oglesbee, Devin / Lieske, John C / Erbe, David V / Wright, John /
    van Heel, David A

    eLife

    2020  Volume 9

    Abstract: By sequencing autozygous human populations, we identified a healthy adult woman with lifelong complete knockout ... ...

    Abstract By sequencing autozygous human populations, we identified a healthy adult woman with lifelong complete knockout of
    MeSH term(s) Adult ; Alcohol Oxidoreductases/antagonists & inhibitors ; Alcohol Oxidoreductases/genetics ; Animals ; CHO Cells ; Cricetulus ; Female ; Glycolates/metabolism ; Humans ; Hyperoxaluria, Primary/metabolism ; Hyperoxaluria, Primary/therapy ; RNAi Therapeutics
    Chemical Substances Glycolates ; glycolic acid (0WT12SX38S) ; Alcohol Oxidoreductases (EC 1.1.-) ; HAO1 protein, human (EC 1.1.3.15)
    Language English
    Publishing date 2020-03-24
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2687154-3
    ISSN 2050-084X ; 2050-084X
    ISSN (online) 2050-084X
    ISSN 2050-084X
    DOI 10.7554/eLife.54363
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top